Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suvorexant in insomnia: efficacy, safety and place in therapy
Danielle N. Rhyne, Sarah L. Anderson
Therapeutic Advances in Drug Safety (2015) Vol. 6, Iss. 5, pp. 189-195
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Insomnia in the Elderly: A Review
Dhaval Patel, Joel Steinberg, Pragnesh Patel
Journal of Clinical Sleep Medicine (2018) Vol. 14, Iss. 06, pp. 1017-1024
Open Access | Times Cited: 505
Sleep disorders in the elderly: Diagnosis and management
Keisuke Suzuki, Masayuki Miyamoto, Koichi Hirata
Journal of General and Family Medicine (2017) Vol. 18, Iss. 2, pp. 61-71
Open Access | Times Cited: 201
Suvorexant for the treatment of primary insomnia: A systematic review and meta-analysis
Akira Kuriyama, Hiromitsu Tabata
Sleep Medicine Reviews (2016) Vol. 35, pp. 1-7
Closed Access | Times Cited: 133
Pharmacological Management of Insomnia
Sarika Madari, Raphael Golebiowski, Meghna P. Mansukhani, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 1, pp. 44-52
Open Access | Times Cited: 85
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
A systematic and robust assessment of hot-melt extrusion-based amorphous solid dispersions: Theoretical prediction to practical implementation
Abdullah Alzahrani, Dinesh Nyavanandi, Preethi Mandati, et al.
International Journal of Pharmaceutics (2022) Vol. 624, pp. 121951-121951
Closed Access | Times Cited: 60
Guidelines for pharmacotherapy in Alzheimer’s disease – A primer on FDA-approved drugs
Ashvin Varadharajan, Aarjith Damian Davis, Aishwarya Ghosh, et al.
Journal of Neurosciences in Rural Practice (2023) Vol. 14, pp. 566-573
Open Access | Times Cited: 32
Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies
Russell Rosenberg, Leslie Citrome, Christopher L. Drake
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 2549-2566
Open Access | Times Cited: 47
Sleep dysregulation in binge eating disorder and “food addiction”: the orexin (hypocretin) system as a potential neurobiological link
Jacqueline B. Mehr, Deborah Mitchison, Hannah E. Bowrey, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2051-2061
Open Access | Times Cited: 46
Orexin receptor antagonists in the pathophysiology and treatment of sleep disorders and epilepsy
Mohammad Sheibani, Maryam Shayan, Mina Khalilzadeh, et al.
Neuropeptides (2023) Vol. 99, pp. 102335-102335
Closed Access | Times Cited: 18
Exploring triazole-based drugs: Synthesis, application, FDA approvals, and clinical trial updates–A comprehensive review
Javed Khan, Anjali Rani, M. Aslam, et al.
Tetrahedron (2024) Vol. 162, pp. 134122-134122
Closed Access | Times Cited: 7
The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia
Sander Brooks, Gabriël E. Jacobs, Peter de Boer, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 2, pp. 202-209
Closed Access | Times Cited: 52
Common Sleep Disorders Affecting Older Adults
Ecler Jaqua, Mary Hanna, Wessam Labib, et al.
The Permanente Journal (2022) Vol. 27, Iss. 1, pp. 122-132
Open Access | Times Cited: 23
Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia
Andrew Hogyu Han, Caroline R. Burroughs, Evan P. Falgoust, et al.
Health psychology research (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 13
The role of the left dorsolateral prefrontal cortex in conflict control during insomnia disorder
Xiaobin Ding, Liang He, Tiejun Kang, et al.
Journal of Psychiatric Research (2024) Vol. 171, pp. 271-276
Closed Access | Times Cited: 5
A review of symptom, pathogenesis and treatment characteristics of the elderly with chronic insomnia
LiBo Xia, Haiyan Liu, Jixiang Ren
Medicine (2025) Vol. 104, Iss. 5, pp. e41346-e41346
Open Access
Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications
W. Joseph Herring, Thomas Roth, Andrew D. Krystal, et al.
Journal of Sleep Research (2018) Vol. 28, Iss. 2
Closed Access | Times Cited: 44
Impact of Sleep Disorder as a Risk Factor for Dementia in Men and Women
Hye Jin Jee, Wonseok Shin, Ho Joong Jung, et al.
Biomolecules & Therapeutics (2019) Vol. 28, Iss. 1, pp. 58-73
Open Access | Times Cited: 42
Sleep during and following critical illness: A narrative review
Laurie Showler, Yasmine Ali Abdelhamid, Jeremy Goldin, et al.
World Journal of Critical Care Medicine (2023) Vol. 12, Iss. 3, pp. 92-115
Open Access | Times Cited: 11
Impact of Orexin-A Treatment on Food Intake, Energy Metabolism and Body Weight in Mice
Anne Blais, Gaëtan Drouin, Catherine Chaumontet, et al.
PLoS ONE (2017) Vol. 12, Iss. 1, pp. e0169908-e0169908
Open Access | Times Cited: 39
Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference
Jed Black, Giora Pillar, Jan Hedner, et al.
Sleep Medicine (2017) Vol. 36, pp. 86-94
Closed Access | Times Cited: 39
Optical probing of orexin/hypocretin receptor antagonists
Shi‐Bin Li, Natalie Nevárez, William J. Giardino, et al.
SLEEP (2018) Vol. 41, Iss. 10
Open Access | Times Cited: 32
The function of sleep and the treatment of primary insomnia
Wolfgang Freund, Frank Weber
Deutsches Ärzteblatt international (2023)
Open Access | Times Cited: 10
Role of orexin in pathogenesis of neurodegenerative parkinsonisms
Piotr Alster, Natalia Madetko, Dagmara Otto‐Ślusarczyk, et al.
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 4, pp. 335-343
Open Access | Times Cited: 9
Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis
Hannah B. Elam, Stephanie M. Perez, Jennifer J. Donegan, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top